These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25866129)

  • 1. Exposure to environmental stressors result in increased viral load and further reduction of production parameters in pigs experimentally infected with PCV2b.
    Patterson R; Nevel A; Diaz AV; Martineau HM; Demmers T; Browne C; Mavrommatis B; Werling D
    Vet Microbiol; 2015 Jun; 177(3-4):261-9. PubMed ID: 25866129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs.
    Opriessnig T; Xiao CT; Gerber PF; Halbur PG; Matzinger SR; Meng XJ
    J Gen Virol; 2014 Nov; 95(Pt 11):2495-2503. PubMed ID: 25053562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection.
    Opriessnig T; Ramamoorthy S; Madson DM; Patterson AR; Pal N; Carman S; Meng XJ; Halbur PG
    J Gen Virol; 2008 Oct; 89(Pt 10):2482-2491. PubMed ID: 18796717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
    Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an interferon-stimulated response element (ISRE) mutant of porcine circovirus type 2 (PCV2) on PCV2-induced pathological lesions in a porcine reproductive and respiratory syndrome virus (PRRSV) co-infection model.
    Ramamoorthy S; Opriessnig T; Pal N; Huang FF; Meng XJ
    Vet Microbiol; 2011 Jan; 147(1-2):49-58. PubMed ID: 20637549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of porcine circovirus type 2 (PCV2)-associated lesions produced by co-infection between two genotypes of PCV2 and two genotypes of porcine reproductive and respiratory syndrome virus.
    Park C; Seo HW; Park SJ; Han K; Chae C
    J Gen Virol; 2014 Nov; 95(Pt 11):2486-2494. PubMed ID: 25034866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in time and magnitude of immune response and viremia in experimental challenges with Porcine circovirus 2b.
    Engle TB; Jobman EE; Moural TW; McKnite AM; Bundy JW; Barnes SY; Davis EH; Galeota JA; Burkey TE; Plastow GS; Kachman SD; Ciobanu DC
    BMC Vet Res; 2014 Dec; 10():286. PubMed ID: 25472653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
    Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant.
    Juhan NM; LeRoith T; Opriessnig T; Meng XJ
    Virus Res; 2010 Jan; 147(1):60-6. PubMed ID: 19852989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markedly different immune responses and virus kinetics in littermates infected with porcine circovirus type 2 or porcine parvovirus type 1.
    Opriessnig T; Gerber PF; Matzinger SR; Meng XJ; Halbur PG
    Vet Immunol Immunopathol; 2017 Sep; 191():51-59. PubMed ID: 28895867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine reproductive and respiratory syndrome virus (PRRSV) influences infection dynamics of porcine circovirus type 2 (PCV2) subtypes PCV2a and PCV2b by prolonging PCV2 viremia and shedding.
    Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Meng XJ; Halbur PG; Opriessnig T
    Vet Microbiol; 2011 Sep; 152(3-4):235-46. PubMed ID: 21641124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2015 May; 177(1-2):43-52. PubMed ID: 25790733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs.
    Opriessnig T; Prickett JR; Madson DM; Shen HG; Juhan NM; Pogranichniy RR; Meng XJ; Halbur PG
    Vet Res; 2010; 41(3):31. PubMed ID: 20167193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental reproduction of postweaning multisystemic wasting syndrome (PMWS) in pigs in Sweden and Denmark with a Swedish isolate of porcine circovirus type 2.
    Hasslung F; Wallgren P; Ladekjaer-Hansen AS; Bøtner A; Nielsen J; Wattrang E; Allan GM; McNeilly F; Ellis J; Timmusk S; Belák K; Segall T; Melin L; Berg M; Fossum C
    Vet Microbiol; 2005 Mar; 106(1-2):49-60. PubMed ID: 15737473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA.
    Shen HG; Halbur PG; Opriessnig T
    J Gen Virol; 2012 Jun; 93(Pt 6):1345-1355. PubMed ID: 22398315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2.
    Opriessnig T; Xiao CT; Gerber PF; Halbur PG
    Vet Microbiol; 2013 Apr; 163(1-2):177-83. PubMed ID: 23305615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
    Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
    Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National reduction in porcine circovirus type 2 prevalence following introduction of vaccination.
    Dvorak CM; Yang Y; Haley C; Sharma N; Murtaugh MP
    Vet Microbiol; 2016 Jun; 189():86-90. PubMed ID: 27259831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
    Guo LJ; Fu YJ; Huang LP; Wang YP; Wei YW; Wu HL; Liu CM
    Vaccine; 2015 Jul; 33(31):3752-7. PubMed ID: 26051516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.